User:Ketul Hasmukhbhai Patel/sandbox

Introduction:
Mr. Anantha Shekhar is an esteemed researcher, educator and entrepreneur. Dr. Shekhar joined the IU School of Medicine workforce in 1989, building up effective fundamental science and clinical research programs in neuropsychiatric issue, eminently alarm and related nervousness issue. Dr. Shekhar holds a few authority posts at IU and IU Health and was named official partner senior member for research issues in August 2015, regulating all examination related exercises at the IU School of Medicine. He is one of six official partner senior members who make up the school's official administration group with Dean Jay L. Hess, MD, PhD.He is an Associate Vice President of Research and University Clinical Affairs at Indiana University. He is the founding director of the nationally recognised Indiana Clinical and Translational Sciences Institute, a results driven partnership among Indiana University, Purdue University and University of Notre Dame, created to improve health of people in Indiana through research. The institute has to date received over $60 million in Clinical and Translational Sciences Awards from the National Center for Advancing Translational Sciences at the National Institutes of Health, plus support from the three member universities, the state of Indiana and public and private partnerships. Dr. Shekhar is the principal investigator of $25 million grant from the National Institute of Health awarded to Indiana University to establish this institute. He is a Director of CHV Capital, Inc. Dr. Shekhar is the Raymond E. Houk Professor and the Associate Dean for Translational Research at Indiana University.

Education:
He holds a Bachelor of Science from St. Joseph's College in Bangalore, India, and a therapeutic degree from St. John's Medical College in Bangalore, India. He served a medical residency and fellowship at the Indiana University School of Medicine. He also holds a Ph.D. in medical neurobiology from Indiana University.

Career and work:
Mr. Anantha Shekhar's specialized topics incorporates essential and clinical research on the impacts of pressure initiated mental and ailments and clinical psychopharmacology.His work bases on the activity of brain variations from the norm that could prompt pressure mental issue and has all the more as of late stretched out his examinations to the revelation of new medications. He directs various establishment bolstered inquires about and examines, including being head agent of longitudinal investigation of sickness hazard factors in Indiana populace, upheld by Fairbanks Institute Of Indiana. . Among his many firsts in the field were reporting specific molecular mechanisms in the brain underlying panic attacks and autism symptoms that develop in children with a genetic condition known as Neurofibromatosis 1, and identifying new therapies to treat patients with post-traumatic .His efforts in developing treatment targets for major psychiatric disorders in patients with schizophrenia. He has lead a basic and clinical research programmes in the areas clinical neuroscience and stress related disorders, funded by National Institute Of Health since 1989.

Dr. Shekhar has composed in excess of 200 logical papers, filled in as an individual from the Board of Scientific Counselors for the National Institute of Mental Health in 2014, and is a tenured member of the Advisory Board for Clinical Research of the National Institutes of Health Clinical Centre.

He recently joined as a member of the Advisory Council for the National Centre for Advancing Translational Sciences and the Board of Governors of the NIH Cures Acceleration Network.

He is serving as a co-chair of the scientific advisory board for the Sino-American Symposium on Clinical and Translational Medicine. The board is a collaboration of medical school deans and health care leaders across the U.S. and China led by Global MD and created to advise the Chinese government on developing a national infrastructure to accelerate translational research in the country.

Dr. Shekhar heads the Precision Health Initiative, a $ 120 million venture to create accuracy restorative research and clinical projects crosswise over Indiana University and it's state wide wellbeing framework IU Health. His work in Precision Medicine which as of late won $100 million award from Indiana University's Grand Challenges Program, which use hereditary testing and progressed investigation to build the treatability of the sickness. In addition to the focus on diseases, the Precision Health involves a ground breaking effort to canvas rural Indiana to collect information and DNA samples from 2,000 residents to understand how genetic, behavioural and environmental factors influence health. The Precision Health Initiative involves colleagues from many IU schools including the School of Medicine; the College of Arts and Sciences at IU Bloomington; the IU School of Informatics, Computing and Engineering on the Bloomington campus and the School of Informatics and Computing on the IUPUI campus; and the School of Nursing.

His start-up company Anagin is developing treatments for post traumatic stress disorder ( PTSD), traumatic brain injury, neuropathic pain, depression, Parkinson's disease and Alzheimer’s disease. Anagin has raised more than $7.5 million for their purpose.

Awards:
August M. Watanabe Life Sciences Champion of The Year Award 2018, a prestigious honour named in tribute to Bio Crossroad’s late Chairman August Watanabe. He has been awarded IURTC Outstanding Innovator Award.

Association:
He is associated with Indiana University Methodist/ IU Health University. He is also associated with Indiana University Health Physicians. Shekhar is a board guaranteed individual from the American Board of Psychiatry and Neurology. He is the main examiner of the Precision Health Initiative, which was the principal beneficiary of financing from the IU Grand Challenges program.

Research article published:
1) https://indiana.pure.elsevier.com/en/publications/activation-of-the-orexin-1-receptor-is-a-critical-component-of-co

/>2) https://indiana.pure.elsevier.com/en/publications/an-animal-model-of-panic-vulnerability-with-chronic-disinhibition

/>3) https://indiana.pure.elsevier.com/en/publications/a-new-facile-synthetic-route-to-11cgsk189254-a-selective-pet-radi

/>4) https://indiana.pure.elsevier.com/en/publications/convergent-functional-genomics-of-schizophrenia-from-comprehensiv

/>5) https://indiana.pure.elsevier.com/en/publications/dorsomedialperifornical-hypothalamic-stimulation-increases-intrao

/>6) https://indiana.pure.elsevier.com/en/publications/overview-of-genetic-models-of-autism-spectrum-disorders

/>7) http://doi.org/10.1007/s00213-017-4645-2

/>8) https://indiana.pure.elsevier.com/en/publications/evaluation-of-jnj-54717793-a-novel-brain-penetrant-selective-orex

/>9) https://indiana.pure.elsevier.com/en/publications/evaluation-of-low-versus-high-volume-per-minute-displacement-cosu

/>10) https://indiana.pure.elsevier.com/en/publications/the-social-symbiome-framework-linking-genes-to-global-cultures-in

References:
Anantha Shekhar – Publications. (n.d.). Retrieved from https://indiana.pure.elsevier.com/en/persons/anantha-shekhar/publications/?page=1.

/>2) https://youtu.be/LjqsGfAU42o

/>3) http://www.insideindianabusiness.com/clip/14653624/biocrossroads-announces-watanabe-winner-new-seed-fund

/>4) http://newsinfo.iu.edu/news-archive/23298.html

/>5) https://www.wndu.com/content/news/Cancer-The-Gene-422029654.html

/>6) https://www.biocrossroads.com/esteemed-researcher-educator-and-entrepreneur-dr-anantha-shekhar-honored-as-2018-watanabe-life-sciences-champion-of-the-year/

/>7) https://www.prnewswire.com/news-releases/biocrossroads-announces-the-formation-of-the-9-million-indiana-seed-fund-iii-invests-in-scioto-biosciences-and-animated-dynamics-300727668.html

/>8) https://www.bloomberg.com/research/stocks/private/person.asp?personId=115506578&privcapId=374119291

/>9) https://www.dailymotion.com/video/x2x74ol

/>10) http://www.jneurosci.org/content/26/26/7093/tab-article-info

/>11) https://youtu.be/blxNo7Zkd60

/>12) https://medicine.iu.edu/news/2015/07/anantha-shekhar-named-iusm-research-dean-1/

/>13) https://youtu.be/KShvV4KTLTs

/>14) http://inscopearchive.iu.edu/features/stories/2013-10-24-CTSI-renewal-inscope.shtml

/>